484 related articles for article (PubMed ID: 29196953)
1. Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages.
Holló G; Katsanos A; Boboridis KG; Irkec M; Konstas AGP
Drugs; 2018 Jan; 78(1):39-64. PubMed ID: 29196953
[TBL] [Abstract][Full Text] [Related]
2. Preservative-free tafluprost/timolol fixed combination: a new opportunity in the treatment of glaucoma.
Konstas AG; Holló G
Expert Opin Pharmacother; 2016 Jun; 17(9):1271-83. PubMed ID: 27123557
[TBL] [Abstract][Full Text] [Related]
3. Effects of benzalkonium chloride- and polyquad-preserved combination glaucoma medications on cultured human ocular surface cells.
Ammar DA; Noecker RJ; Kahook MY
Adv Ther; 2011 Jun; 28(6):501-10. PubMed ID: 21603985
[TBL] [Abstract][Full Text] [Related]
4. Tafluprost/Timolol: A Review in Open-Angle Glaucoma or Ocular Hypertension.
Hoy SM
Drugs; 2015 Oct; 75(15):1807-13. PubMed ID: 26431840
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of tafluprost 0.0015% and timolol maleate 0.5% fixed combination in patients with ocular hypertension or open-angle glaucoma.
Lorenz K; Pfeiffer N
Expert Opin Pharmacother; 2014 Oct; 15(15):2255-62. PubMed ID: 25170534
[TBL] [Abstract][Full Text] [Related]
6. Reviewing the evidence surrounding preservative-free tafluprost/timolol fixed-dose combination therapy in open-angle glaucoma and ocular hypertension management: a focus on efficacy, safety, and tolerability.
Oddone F
Expert Opin Drug Saf; 2022 Oct; 21(10):1259-1268. PubMed ID: 36250245
[TBL] [Abstract][Full Text] [Related]
7. Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells.
Ammar DA; Kahook MY
Mol Vis; 2011; 17():1806-13. PubMed ID: 21750606
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety evaluation of benzalkonium chloride preserved eye-drops compared with alternatively preserved and preservative-free eye-drops in the treatment of glaucoma: a systematic review and meta-analysis.
Hedengran A; Steensberg AT; Virgili G; Azuara-Blanco A; Kolko M
Br J Ophthalmol; 2020 Nov; 104(11):1512-1518. PubMed ID: 32051133
[TBL] [Abstract][Full Text] [Related]
9. An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology.
Martone G; Frezzotti P; Tosi GM; Traversi C; Mittica V; Malandrini A; Pichierri P; Balestrazzi A; Motolese PA; Motolese I; Motolese E
Am J Ophthalmol; 2009 Apr; 147(4):725-735.e1. PubMed ID: 19181302
[TBL] [Abstract][Full Text] [Related]
10. Latanoprost : an update of its use in glaucoma and ocular hypertension.
Perry CM; McGavin JK; Culy CR; Ibbotson T
Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
[TBL] [Abstract][Full Text] [Related]
11. Overview of the [corrected] travoprost /timolol BAK-free fixed combination.
Konstas AG; Quaranta L; Realini T
Expert Opin Pharmacother; 2012 Apr; 13(5):757-66. PubMed ID: 22360540
[TBL] [Abstract][Full Text] [Related]
12. In vivo confocal microscopy of conjunctiva in preservative-free timolol 0.1% gel formulation therapy for glaucoma.
Frezzotti P; Fogagnolo P; Haka G; Motolese I; Iester M; Bagaglia SA; Mittica P; Menicacci C; Rossetti L; Motolese E
Acta Ophthalmol; 2014 Mar; 92(2):e133-40. PubMed ID: 24020826
[TBL] [Abstract][Full Text] [Related]
13. [Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent].
Mlčáková E; Mlčák P; Karhanová M; Langová K; Marešová K
Cesk Slov Oftalmol; 2016; 72(4):120-127. PubMed ID: 27860477
[TBL] [Abstract][Full Text] [Related]
14. In vitro effects of preserved or preservative-free antiglaucoma medications on human complement system.
Blondin C; Hamard P; Cholley B; Haeffner-Cavaillon N; Baudouin C
Curr Eye Res; 2003 Oct; 27(4):253-9. PubMed ID: 14562177
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of preservative-free eye drops containing a fixed combination of dorzolamide and timolol in glaucoma patients.
Renieri G; Führer K; Scheithe K; Lorenz K; Pfeiffer N; Thieme H
J Ocul Pharmacol Ther; 2010 Dec; 26(6):597-603. PubMed ID: 20977366
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy and safety of preserved versus preservative-free beta-blockers in patients with glaucoma or ocular hypertension: a systematic review.
Skov AG; Rives AS; Freiberg J; Virgili G; Azuara-Blanco A; Kolko M
Acta Ophthalmol; 2022 May; 100(3):253-261. PubMed ID: 34128326
[TBL] [Abstract][Full Text] [Related]
17. A review of preserved and preservative-free prostaglandin analogues for the treatment of open-angle glaucoma and ocular hypertension.
Hommer A
Drugs Today (Barc); 2010 Jun; 46(6):409-16. PubMed ID: 20571609
[TBL] [Abstract][Full Text] [Related]
18. Fixed topical combinations in glaucomatous patients and ocular discomfort.
Nebbioso M; Evangelista M; Librando A; Di Blasio D; Pescosolido N
Expert Opin Pharmacother; 2012 Sep; 13(13):1829-35. PubMed ID: 22770575
[TBL] [Abstract][Full Text] [Related]
19. Tafluprost: the first preservative-free prostaglandin to treat open-angle glaucoma and ocular hypertension.
Swymer C; Neville MW
Ann Pharmacother; 2012 Nov; 46(11):1506-10. PubMed ID: 23092867
[TBL] [Abstract][Full Text] [Related]
20. Brinzolamide/timolol fixed combination: a new ocular suspension for the treatment of open-angle glaucoma and ocular hypertension.
Holló G; Bozkurt B; Irkec M
Expert Opin Pharmacother; 2009 Aug; 10(12):2015-24. PubMed ID: 19618994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
